A novel algorithm to differentiate between primary lung tumors and distant liver metastasis in lung cancers using an exosome based multi gene biomarker panel

  • 0Division of Biological and Life Science, Ahmedabad University, Ahmedabad, Gujarat, India.

|

|

Summary

This summary is machine-generated.

A novel blood-based exosomal biomarker panel aids in early lung cancer liver metastasis detection and monitoring. This diagnostic tool improves patient prognosis through accurate risk assessment and survival prediction.

Area Of Science

  • Oncology
  • Biomarker Discovery
  • Molecular Diagnostics

Background

  • Lung cancer liver metastasis (LCLM) significantly worsens patient prognosis due to a lack of early detection methods.
  • Non-invasive diagnostic tools are crucial for timely intervention and improved outcomes in LCLM patients.

Purpose Of The Study

  • To identify and validate circulating biomarkers for early diagnosis and monitoring of LCLM.
  • To develop a predictive model using exosomal biomarkers for LCLM detection and prognosis.

Main Methods

  • Validated an 8-gene panel in circulating tumor cells (CTC), cell-free RNA (cfRNA), and exosomes.
  • Utilized multivariate analysis (PCA, ROC) to assess biomarker panel sensitivity and specificity.
  • Validated a predictive model in a separate cohort and analyzed survival and immune infiltration correlations.

Main Results

  • An 8-gene exosomal panel showed good discriminative value (AUC 0.7247).
  • A refined 5-gene panel achieved high AUCs of 0.9488 (tissue) and 0.9924 (exosomes).
  • A validated model with a risk score (RS > 0.2) predicted LCLM with 95% accuracy; four exosomal markers correlated with poor survival.

Conclusions

  • A novel blood-based exosomal biomarker panel enables early diagnosis of LCLM.
  • The panel facilitates monitoring of therapeutic response and prognostic evaluation in LCLM patients.
  • This non-invasive approach holds promise for improving LCLM patient management.